Key Laboratory of Modern Preparation of TCM, Ministry of Education, Jiangxi University of Traditional Chinese Medicine, Nanchang, Jiangxi, 330004,
Department of Medicine and Pharmacy, 94th Hospital of People's Liberation Army, Nanchang, Jiangxi, 330002, China.
Int J Nanomedicine. 2018 Jun 28;13:3763-3779. doi: 10.2147/IJN.S164228. eCollection 2018.
The current study sought to design a quickly dissolving, high drug loading nanocrystal-based solid dispersion (NC-SD) in order to improve the dissolution of poorly soluble drugs.
The NC-SD was prepared by means of combination of homogenization and spray-drying. Polymer hydroxypropylmethylcellulose (HPMC) was used as baseline dispersant for NC-SD of the model drug - andrographolide (AG). Three superdisintegrants cohomogenized with HPMC were used as codispersant for AG-NC-SD and compared to common water-soluble dispersants - mannitol and lactose. The dissolution characterization and oral bioavailability of AG-NC-SD were evaluated.
The AG-NC-SD with the higher concentration of HPMC exhibited fast dissolution due to the enhanced wettability of HPMC. The water-soluble codispersants (mannitol and lactose) did not completely prevent AG-NC from aggregation during spray-drying. To achieve much faster AG release, cohomogenized superdisintegrants at a level of 20% must be used along with 25% HPMC. Compared with water-soluble dispersants like mannitol and lactose, superdisintegrants with high swelling capacity were much more effective dispersants for enhancing fast redispersion/dissolution of AG-NC-SD via a swelling-triggered erosion/disintegration mechanism. Surfactant-free AG-NC-SD with 15% cohomogenized sodium carboxymethyl starch combined with 15% HPMC and 10% lactose enhanced the dissolution further, without comprising drug loading, exhibited a barely compromised dissolution rate compared to precursor NC suspensions (>50), and possessed drug loading up to 67.83%±1.26%. The pharmacokinetics results also demonstrated that the AG-NC-SD significantly improved the bioavailability in vivo of AG (<0.05), compared with to the coarse AG.
This study illustrates that a quickly dissolving, high drug load, surfactant-free NC-SD can be prepared by using a superdisintegrant as codispersant, and provides a feasible strategy to improve the oral bioavailability of poorly soluble drugs.
本研究旨在设计一种快速溶解、高载药量的纳米晶固体制剂(NC-SD),以提高难溶性药物的溶解度。
通过匀化和喷雾干燥相结合的方法制备 NC-SD。聚合物羟丙基甲基纤维素(HPMC)被用作模型药物穿心莲内酯(AG)NC-SD 的基础分散剂。三种超崩解剂与 HPMC 共溶,作为 AG-NC-SD 的共分散剂,并与常用的水溶性分散剂甘露醇和乳糖进行比较。对 AG-NC-SD 的溶解特性和口服生物利用度进行了评价。
由于 HPMC 的润湿性增强,载药量较高的 AG-NC-SD 表现出快速溶解。水溶性共分散剂(甘露醇和乳糖)在喷雾干燥过程中不能完全阻止 AG-NC 聚集。为了实现更快的 AG 释放,必须与 25%的 HPMC 一起使用共溶的超崩解剂 20%。与甘露醇和乳糖等水溶性分散剂相比,具有高溶胀能力的超崩解剂通过溶胀触发的侵蚀/崩解机制,是增强 AG-NC-SD 快速再分散/溶解的更有效分散剂。不含表面活性剂的 AG-NC-SD,载药量为 67.83%±1.26%,载药量为 15%的共溶羧甲基淀粉钠与 15%的 HPMC 和 10%的乳糖结合,进一步提高了药物的溶解度,而不会影响药物的载药量,与前体 NC 混悬剂相比,药物的溶解速率几乎没有降低(>50),且生物利用度提高了。药代动力学结果也表明,与粗 AG 相比,AG-NC-SD 显著提高了 AG 的体内生物利用度(<0.05)。
本研究表明,可使用超崩解剂作为共分散剂制备快速溶解、高载药量、不含表面活性剂的 NC-SD,为提高难溶性药物的口服生物利用度提供了一种可行的策略。